GENETIC CONTROL OF VULVAL CELL FATES IN C ELEGANS

线虫外阴细胞命运的遗传控制

基本信息

  • 批准号:
    2182307
  • 负责人:
  • 金额:
    $ 25.71万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1991
  • 资助国家:
    美国
  • 起止时间:
    1991-01-01 至 1998-12-31
  • 项目状态:
    已结题

项目摘要

The long-term objective of the proposed research is to understand how cell signalling leads to the induction of specific cell fates during development. A well-studied example of cell signalling is the induction of the hermaphrodite vulva during development in C. elegans. Genetic and molecular analyses have shown that the response to this inductive signal is mediated by a receptor tyrosine kinase/Ras signal transduction pathway that has been remarkably well conserved during metazoan evolution. While the chain of events leading to the activation of the last signal transduction protein (MAP kinase) has been well described, little is known about the events that occur after MAP kinase activation. Thus, a fundamentally important and yet poorly understood step is how the last signal transduction molecule(s) in this cell signaling pathway regulates the activity of transcription factors in the nucleus, ultimately resulting in cellular differentiation. Furthermore, it is not clear how activation of the same signal transduction pathway at multiple times during development can elicit markedly different cellular responses in different cell types. The proposed research is directed at defining the molecular mechanisms that link activation of this signal transduction cascade with specific changes in gene expression that result in the execution of specific cell fates. One goal is to define the role of two C. elegans MAP kinase homologs that have recently been shown to function in vulval induction. Another goal is to determine how MAP kinases regulate the activity of LIN- 31, a transcription factor that controls vulval gene expression. A third goal is to determine how LIN-31 regulates the choice of induced versus uninduced cell fates during vulval induction, and whether LIN-31 plays a role in defining the cell-type specificity of the transcriptional response to activation of the signal transduction cascade. A final goal is to genetically identify additional genes that act downstream of MAP kinases, in order to define additional links between activation of MAP kinases and induction of vulval cell fates. Because the receptor tyrosine kinase/Ras signal transduction pathway is so highly conserved, and because constitutive activation of this signaling pathway is known to be oncogenic in mammals, the proposed studies will be directly relevant to cell signalling processes in humans, both during normal development and in tumorigenesis.
拟议研究的长期目标是了解细胞如何

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

STUART K KIM其他文献

STUART K KIM的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('STUART K KIM', 18)}}的其他基金

2-photon microscope
2光子显微镜
  • 批准号:
    7595496
  • 财政年份:
    2009
  • 资助金额:
    $ 25.71万
  • 项目类别:
High-throughput technology for automated single cell expression analysis for C. e
用于大肠杆菌自动单细胞表达分析的高通量技术
  • 批准号:
    7830334
  • 财政年份:
    2009
  • 资助金额:
    $ 25.71万
  • 项目类别:
High-throughput technology for automated single cell expression analysis for C. e
用于大肠杆菌自动单细胞表达分析的高通量技术
  • 批准号:
    7937888
  • 财政年份:
    2009
  • 资助金额:
    $ 25.71万
  • 项目类别:
Mechanisms of Aging in C. elegans
线虫的衰老机制
  • 批准号:
    8437842
  • 财政年份:
    2007
  • 资助金额:
    $ 25.71万
  • 项目类别:
Mechanisms of Aging in C elegans
线虫的衰老机制
  • 批准号:
    7602970
  • 财政年份:
    2007
  • 资助金额:
    $ 25.71万
  • 项目类别:
Mechanisms of Aging in C elegans
线虫的衰老机制
  • 批准号:
    7407992
  • 财政年份:
    2007
  • 资助金额:
    $ 25.71万
  • 项目类别:
Mechanisms of Aging in C. elegans
线虫的衰老机制
  • 批准号:
    8811904
  • 财政年份:
    2007
  • 资助金额:
    $ 25.71万
  • 项目类别:
Mechanisms of Aging in C elegans
线虫的衰老机制
  • 批准号:
    8059712
  • 财政年份:
    2007
  • 资助金额:
    $ 25.71万
  • 项目类别:
Mechanisms of Aging in C elegans
线虫的衰老机制
  • 批准号:
    7261158
  • 财政年份:
    2007
  • 资助金额:
    $ 25.71万
  • 项目类别:
Mechanisms of Aging in C elegans
线虫的衰老机制
  • 批准号:
    7843627
  • 财政年份:
    2007
  • 资助金额:
    $ 25.71万
  • 项目类别:

相似海外基金

Development of B cell functional studies on primary antibody deficiencies
一抗缺陷 B 细胞功能研究的进展
  • 批准号:
    502607
  • 财政年份:
    2024
  • 资助金额:
    $ 25.71万
  • 项目类别:
Thymus antibody-secreting cells: major players in autoimmunity.
胸腺抗体分泌细胞:自身免疫的主要参与者。
  • 批准号:
    502578
  • 财政年份:
    2024
  • 资助金额:
    $ 25.71万
  • 项目类别:
ICF: AbVax Combination vaccination and broadly neutralising antibody therapy in HIV to induce a protective Tcell vaccinal effect, a mechanistic study
ICF:AbVax 联合疫苗接种和广泛中和 HIV 抗体疗法诱导保护性 T 细胞疫苗效应,一项机制研究
  • 批准号:
    MR/Y008847/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.71万
  • 项目类别:
    Research Grant
Enabling The Targeted Delivery Of DNA G-quadruplex Ligands using a Novel Antibody DAR-1 Platform
使用新型抗体 DAR-1 平台实现 DNA G 四链体配体的靶向递送
  • 批准号:
    BB/Y002180/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.71万
  • 项目类别:
    Research Grant
Antibody-Palladium Conjugates for Bioorthogonal Anti-Cancer Prodrug Activation
用于生物正交抗癌前药激活的抗体-钯缀合物
  • 批准号:
    EP/Y024540/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.71万
  • 项目类别:
    Fellowship
The delivery of miR-9 and RasGRP4 siRNA via high selectivity bispecific antibody conjugated lactosome: Targeting therapy for rheumatoid arthritis (RA) active synovial macrophage and osteoclast
通过高选择性双特异性抗体缀合乳糖体递送 miR-9 和 RasGRP4 siRNA:类风湿性关节炎 (RA) 活性滑膜巨噬细胞和破骨细胞的靶向治疗
  • 批准号:
    24K19237
  • 财政年份:
    2024
  • 资助金额:
    $ 25.71万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
A Semi-Automated Antibody-Discovery Platform to Target Challenging Biomolecules
针对具有挑战性的生物分子的半自动化抗体发现平台
  • 批准号:
    MR/Y003616/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.71万
  • 项目类别:
    Fellowship
Monitoring antibody protection against SARS-CoV-2 variants
监测抗体对 SARS-CoV-2 变体的保护作用
  • 批准号:
    MR/Y033698/1
  • 财政年份:
    2024
  • 资助金额:
    $ 25.71万
  • 项目类别:
    Research Grant
Autoantibodies and antibody-secreting cells in neurological autoimmune diseases: from biology to therapy
神经性自身免疫性疾病中的自身抗体和抗体分泌细胞:从生物学到治疗
  • 批准号:
    479128
  • 财政年份:
    2023
  • 资助金额:
    $ 25.71万
  • 项目类别:
    Operating Grants
Pharmacokinetic analysis of antibody drug conjugate in tumor cells utilizing synchrotron soft X-ray imaging
利用同步加速器软 X 射线成像对肿瘤细胞中抗体药物偶联物进行药代动力学分析
  • 批准号:
    23H03716
  • 财政年份:
    2023
  • 资助金额:
    $ 25.71万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了